AVO Cream
- Manufacturer
- Trigen Laboratories, LLC
- Effective date
- 2022-01-20
- Label type
- PRESCRIPTION MEDICAL DEVICE LABEL
- Version
- 6
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 21:02:19
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
DESCRIPTION
AVO CreamTMTopical Emulsion is a water-based emulsion formulated for the dressing and management of superficial wounds, minor abrasions, dermal ulcers, donor sites, 1st and 2nd degree burns, including sunburns, and radiation dermatitis. When applied properly to a wound, AVO CreamTM Topical Emulsion provides an optimum moist environment for the healing process and provides temporary wound protection from harmful germs and other external contamination.
INDICATIONS FOR USE
AVO CreamTMTopical Emulsion is indicated for use in:
- Full Thickness Wounds, Pressure Sores, Dermal Ulcers including Lower Leg Ulcers
- Superficial Wounds
- 1st and 2nd Degree Burns, including Sunburns
- Dermal Donor and Graft Site Management
- Radiation Dermatitis
- Minor Abrasions
CONTRAINDICATIONS
AVO CreamTM Topical Emulsion is contraindicated for use on bleeding wounds, skin rashes related to food or medicine allergies, and when an allergy to one of the ingredients is known.
WARNINGS
- In radiation therapy, AVO CreamTM Topical Emulsion may be applied as directed by the treating physician. Do not apply 4 hours prior to a radiation session.
- Do not apply AVO CreamTM Topical Emulsion to dermal grafts until after the graft has successfully taken.
- Keep out of the reach of children.
PRECAUTIONS AND OBSERVATIONS
- For the treatment of any dermal wound, consult a physician. Use AVO CreamTM Topical Emulsion only as directed.
- AVO CreamTM Topical Emulsion is non-toxic. It is for topical use only and should not be ingested or taken internally.
- AVO CreamTM Topical Emulsion does not contain a sunscreen and should not be used prior to extended exposure to the sun.
- The use of AVO CreamTM Topical Emulsion on skin rashes due to allergies has not been studied sufficiently and therefore is not recommended.
- Following the application of AVO CreamTMTopical Emulsion a temporary tingling sensation may occur (10 to 15 minutes).
- If clinical signs of infection are present, appropriate treatment should be initiated. If clinically indicated, use of AVO CreamTM Topical Emulsion may be continued during the anti-infective therapy.
- If condition does not improve within 10-14 days, consult a physician.
- AVO CreamTM Topical Emulsion may dissolve fuchsin when this dye is used to define the margins of the radiation fields to be treated.
INSTRUCTIONS FOR USE
AVO CreamTM Topical Emulsion is for topical use only as directed by a healthcare professional.
Wounds, Abrasions, Full Thickness Wounds, Dermal Graft Site Management and Donor Site Management.
- Wash the affected area(s) with saline, clean water, or a suitable wound cleanser.
- Apply AVO CreamTM Topical Emulsion on and around the affected area(s) in thick layers 1/4 to 1/2 inch thick.
- If applying gauze dressing, moisten the dressing lightly before application.
- Reapply AVO CreamTM Topical Emulsion as described above every 24 to 48 hours or as directed until the wound or lesion has healed fully.
- For donor site management, apply AVO CreamTM Topical Emulsion after skin removal and cover with a moist dressing. Reapply as directed.
- For dermal graft site management, apply AVO CreamTM Topical Emulsion to the graft site only after the graft has taken successfully. AVO CreamTM Topical Emulsion can be washed away with a saline solution or clean water without causing damage to the newly formed tissues.
1st and 2nd Degree Burns, including Sunburns
- Before application of AVO CreamTM Topical Emulsion to burns, take precaution in removing any clothing in the affected area(s).
- Apply AVO CreamTM Topical Emulsion as soon as possible on and around the affected area(s), in a thick 1/4 to 1/2 inch layer until the skin no longer absorbs the product. A white waxy residue may remain. If pain from burn persists, apply thinner layers of AVO CreamTM Topical Emulsion until the pain has ceased.
- Continue to apply AVO CreamTM Topical Emulsion until the affected area(s) has healed completely
- Application of AVO CreamTMTopical Emulsion to the affected area(s) should continue during any subsequent physical therapy treatments.
Radiation Dermatitis
- Apply a generous amount of AVO CreamTM Topical Emulsion three times per day, seven days a week to the treated area(s), gently massaging the area(s) until AVO CreamTM Topical Emulsion is completely absorbed.
- AVO CreamTM Topical Emulsion may be applied as indicated by the treating physician (see WARNINGS).
- Continue to apply AVO CreamTM Topical Emulsion as described above until the skin has fully recovered.
- Do not interrupt applications during the course of radiation therapy, even for one day.
- Do not apply AVO CreamTM Topical Emulsion 4 hours prior to a radiation session.
INGREDIENTS
AVO CreamTM Topical Emulsion contains algin, avocado oil, cetyl palmitate, glycol stearate, mineral oil, paraffin, potassium sorbate, propylene glycol, purified water, sodium methylparaben, sodium propylparaben, squalane, stearic acid and triethanolamine.
HOW SUPPLIED
AVO CreamTM Topical Emulsion is supplied in a:
45 gram tube Product Code: 13811-565-45
90 gram tube Product Code: 13811-565-90
STORAGE
Store at controlled room temperature 15°C - 30°C (59°F - 86°F). [See USP]. Do not freeze.
Call your doctor about side effects. You may report side effects by calling 1-770-509-4500.
KEEP OUT OF THE REACH OF CHILDREN.
Rx Only - Prescription Medical Device: Federal Law restricts this device to sale by or on the order of a physician (or properly licensed practitioner).
Manufactured for:
TRIGEN Laboratories, LLC
Alpharetta, GA 30005
PLR-AVO-00005-1 Rev. 01/2022

PRINCIPAL DISPLAY PANEL - 90 GRAM CARTON
PRINCIPAL DISPLAY PANEL - 45 GRAM CARTON
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL - 45 Gram Carton Label
13811-565-45
Rx Only
AVO CreamTM Topical Emulsion
For Topical Dermatological Use Only
PRINCIPAL DISPLAY PANEL - 90 GRAM TUBE
PRINCIPAL DISPLAY PANEL - 45 GRAM TUBE
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 13811-565-45 | GM - Gram | 13811-565 | 73fbcab2-a6da-419b-ae4c-011238e12881 | 1 | 2013-08-02 |
| 13811-565-90 | GM - Gram | 13811-565 | 8f8b8fee-2423-49bb-9d6a-00879573565d | 1 | 2013-08-02 |
Products#
Every source-derived product name is available through these pages.
- AVO Cream
- WATER
- STEARIC ACID
- PROPYLENE GLYCOL
- MINERAL OIL
- SODIUM ALGINATE
- GLYCOL STEARATE
- PARAFFIN
- SQUALANE
- AVOCADO OIL
- CETYL PALMITATE
- METHYLPARABEN
- PROPYLPARABEN
- TROLAMINE
- SORBIC ACID
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 13811-565 | 13811-565-45, 13811-565-90 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| WATER | 059QF0KO0R | INGR |
| STEARIC ACID | 4ELV7Z65AP | INGR |
| PROPYLENE GLYCOL | 6DC9Q167V3 | INGR |
| MINERAL OIL | T5L8T28FGP | INGR |
| SODIUM ALGINATE | C269C4G2ZQ | INGR |
| GLYCOL STEARATE | 0324G66D0E | INGR |
| PARAFFIN | I9O0E3H2ZE | INGR |
| SQUALANE | GW89575KF9 | INGR |
| AVOCADO OIL | 6VNO72PFC1 | INGR |
| CETYL PALMITATE | 5ZA2S6B08X | INGR |
| METHYLPARABEN | A2I8C7HI9T | INGR |
| PROPYLPARABEN | Z8IX2SC1OH | INGR |
| TROLAMINE | 9O3K93S3TK | INGR |
| SORBIC ACID | X045WJ989B | INGR |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sterile Water | WATER | REMEDYREPACK INC. | 5dd5d148-6e23-41de-bff5-551b2aea9598 | 2026-08-24 | Warnings, Adverse reactions | WATER |
| NINA WATER (Rich anions,Alkaline Balancing Water) | WATER | DMBIO.CO.,LTD. | 58cbda7e-70c9-af85-e063-6394a90a0d17 | 2026-08-11 | Warnings | WATER |
| NINA WATER (Rich anions,Alkaline Balancing Water) | WATER | DMBIO.CO.,LTD. | 58b9b24c-7014-eb45-e063-6294a90ae482 | 2026-08-10 | Warnings | WATER |
| Sterile Water | WATER | Cardinal Health 107, LLC | 48d75a7c-8329-48a8-bea0-a8c144ddf637 | 2026-08-07 | Warnings, Adverse reactions | WATER |
| Sterile Water | WATER | Cardinal Health 107, LLC | 9655cd02-82b5-4a75-813b-854b19551481 | 2026-07-21 | Warnings, Adverse reactions | WATER |
| Remodulin | TREPROSTINIL | United Therapeutics Corporation | 6c80bb38-e8db-4138-9f0d-dbbf9c673185 | 2026-07-02 | Warnings, Adverse reactions | WATER |
| Sterile Water | WATER | Hospira, Inc. | 3a6422e1-feee-4095-8883-2b0837039e6e | 2026-05-07 | Warnings, Adverse reactions | WATER |
| NINA WATER (Rich anions) | WATER | BIOHERB Co., Ltd. | 16053e79-189e-4cdf-e063-6394a90ac776 | 2026-04-11 | Warnings | WATER |
| Sterile Water | WATER | Hospira, Inc. | 2b9ea23a-f9e9-48a8-25b7-519e3bbd6828 | 2026-03-18 | Warnings, Adverse reactions | WATER |
| INSULIN DILUTING MEDIUM FOR Kirsty | WATER | Biocon Biologics Inc. | 3db1d482-7e1f-aec6-79ef-3f305b4d8277 | 2026-01-20 | Warnings, Adverse reactions | WATER |
| pH Neutral Emergency Eyewash | WATER | INNOVATIVE SAFETY SUPPLY INC. | 29a1bd1e-d0dd-478f-e063-6394a90ab0aa | 2026-01-08 | Warnings | WATER |
| Quality Choice Eye Wash | WATER | Chain Drug Marketing Assoc., Inc. | 1fb8a109-351b-7039-e063-6394a90a7311 | 2025-12-30 | Warnings | WATER |
| OCUFRESH | WATER | Optics Laboratory Inc. | b8e477a9-66b9-496b-92fb-3d4bbd7b36b5 | 2025-12-29 | Warnings | WATER |
| Sterile Water | WATER | ProPharma Distribution | 386a0a2f-4ff7-f128-e063-6294a90a7d4d | 2025-12-18 | Warnings, Adverse reactions | WATER |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | beda35c3-9a8b-47ad-e053-2995a90a7b1b | 2025-11-24 | Warnings | WATER |
| Easy Care First Aid Eyewash | WATER | Tender Corporation | a070aac8-e6d2-ef10-e053-2a95a90aa5b1 | 2025-11-24 | Warnings | WATER |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | e07a064b-f680-405c-bbcd-24fac430951e | 2025-11-24 | Warnings | WATER |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 777e1559-786f-8d54-e053-2991aa0aa98d | 2025-11-24 | Warnings | WATER |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 7289103a-5cbf-42f4-8848-e827149a43ca | 2025-11-24 | Warnings | WATER |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | fd823bef-c14c-4708-a18a-8aaa8470412f | 2025-11-18 | Warnings, Adverse reactions | WATER |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.



